Northern Trust
NEPH icon

Northern Trust’s Nephros NEPH Stock Holding History

Northern Trust’s Portfolio NEPH Stock Details NEPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.6K Buy
16,706
+5,878
+54% +$19.1K ﹤0.01% 4236
2026
Q1 		$32.3K Hold
10,828
– – ﹤0.01% 4298
2025
Q4 		$52.8K Buy
+10,828
New +$55.3K ﹤0.01% 4267

Other funds holding NEPH

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CC
Cornerstone Capital Palo Alto, California $1.12B AUM 28.84% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Northern Trust's NEPH Position: Q2 2026 in Review

Northern Trust increased its Nephros (NEPH) stake by 54% in Q2 2026, buying an estimated $19.1K and bringing the position to 16,706 shares worth $59.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4236.

Northern Trust first reported a position in NEPH in Q4 2025 and has held it in 3 quarters since. 33 funds tracked by Wall St. Rank hold NEPH as of Q2 2026.

  • Northern Trust held 16,706 shares of Nephros worth $59.6K as of Q2 2026.
  • Northern Trust bought 5,878 Nephros shares in Q2 2026, an estimated $19.1K.
  • Nephros made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4236 holding.
  • Northern Trust first reported a position in Nephros in Q4 2025 and has held it in 3 quarters since.
  • 33 funds tracked by Wall St. Rank held Nephros as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.